Oncological Pain and Clinical Approaches


Drug

Mechanism of action

Adverse effects

Precautions

Starting daily dose

Titration

Maximum daily dose

Tricyclic antidepressants

Nortriptyline

Serotonin/norepinephrine reuptake inhibition; sodium channels block; anticholinergic effect

Sedation; dry mouth; urinary retention; weight gain

Cardiovascular disease; glaucoma; seizure disorder; interaction with drugs metabolized by cytochrome P450 2D6

10–25 mg nightly

10–25 mg increase every 3–7 days

75–150 mg

Desipramine

SSNRIs

Duloxetine

Serotonin and norepinephrine reuptake inhibition

Nausea; xerostomia;

Hepatic and renal insuffi ciency; alcohol abuse, use of tramadol

20–30 mg

No evidence that higher dose is more effective

120 mg

Calcium channel α2-δ ligands

Gabapentin

Glutamate, norepinephrine, and substance P release inhibition

Sedation, dizziness, peripheral oedema, gastrointestinal symptoms

Renal insuffi ciency

100–300 mg nightly or 3 times/day

100–300 mg every 1–7 days

3,600 mg

Pregabalin

As gabapentin

As gabapentin

As gabapentin

25–50 mg 3 times/day

50 mg increase after 1 week

200 mg 3 times/day

Topical lidocaine

5 % lidocaine patch

Sodium channels block

Local erythema/rash

None

3 patches/day

Non-applicable

3 patches/day



Although the use of concomitant drugs is usually avoided due to the risk of additive side effects, drug-drug interactions and non-compliance, combination therapy may be useful for neuropathic pain control. Extended-release morphine combined with pregabalin or gabapentin have been successfully used. Nortriptyline with gabapentin or pregabalin with topical lidocaine are other combinations that have shown to provide a better pain relief than that achieved with each drug alone [108].

Interventional therapies, indicated for those patients who do not respond to pharmacological therapy, or only respond partially, are discussed later.





  • Ectopic nerve activity, central sensitisation, inflammation, loss of inhibitory neurons and sympathetic fibres involvement are the main mechanisms underlying neuropathic pain onset and maintenance.


  • Anticonvulsants are widely used for the treatment of neuropathic pain with good results. They are well-tolerated drugs with no known drug-drug interactions.


  • Tricyclic antidepressants have also shown to be effective, leading to pain relief in a few days. Doses should be initially low and careful titration must be performed since the adverse effect profile of these drugs is highly variable due to genetic polymorphisms.


  • NSRIs are also effective in the treatment of neuropathic pain, in addition to their therapeutic role in depression, often associated with pain. Several antidepressants, though, have an important inhibitory effect on cytochrome P450 enzymes.


  • Although opioids may be effective for neuropathic pain treatment, higher doses are usually required, possibly resulting in intolerable adverse effects for most patients.


  • Lidocaine patches have negligible side effects and are a good option for localised peripheral neuropathic pain.


  • Interventional therapies are indicated for those patients who do not respond to pharmacological therapy or who experience major drug adverse effects.



39.16.3 Pain Caused by Bowel Obstruction


Pharmacological treatment of bowel obstruction pain is indicated for inoperable patients and aims to relieve abdominal continuous pain as well as intestinal colic. The prescribed analgesics are mainly strong opioids, but for refractory colic hyoscine butylbromide or hyoscine hydrobromide, two anti-cholinergic drugs, may be used in association to opioids. The preferred routes of administration are subcutaneous, intravenous and transdermal [121].


39.16.4 Adjuvant Interventions


Interventional techniques consist of invasive approaches that provide temporary or permanent interruption of nerve transmission. Even when optimal pharmacological therapy is provided, it is estimated that 10 % of patients suffer from refractory pain [122]. This corresponds, in most cases, to neuropathic and bone pain. For these patients, as well as for those who experience major adverse effects from analgesic therapy, those techniques may be useful, as part of a multimodal approach [123].

Many patients undergoing these procedures are being treated with high dose opioids. This implies the risk for respiratory depression and excessive sedation as a result of a successful intervention. Careful monitoring of respiratory function is therefore mandatory and an appropriate reduction of opioid doses must be performed. Often, half the usual dose is administered immediately after the procedure and a subsequent further reduction is performed in order to avoid a withdrawal syndrome [123]. Peripheral nerve blocks, neurolytic sympathetic blocks, neuraxial analgesia, vertebroplasty and kyphoplasty are the main interventional procedures for cancer pain relief.


39.16.5 Peripheral Nerve Blocks


Peripheral nerve blocks with local anaesthetics have a limited use in the management of cancer pain. However, they may be useful for acute pain control or to provide short-term analgesia while other therapeutic approaches are implemented. Acute pain control may be needed on the perioperative setting or for other acute events, such as pathological rib fractures, when an intercostal nerve blockade, by means of a bolus injection of local anaesthetics, may be beneficial. Alternatively, catheter infusions adjacent to nerve plexuses, such as the brachial plexus, or other peripheral nerves may provide pain relief for days or weeks. Implantation of catheters into the intrapleural space to anaesthetise the intercostal nerves, and, additionally, the thoracic sympathetic chain, is used, especially for post-thoracotomy pain control, although there are early reports of its use for pain control in the terminally ill patient, with good results in a selected population of patients [124, 125]. The onset of pneumothorax and the risk for local anaesthetic toxicity limits its use [126]. Furthermore, the presence of advanced malignant disease often distorts the normal neuroanatomy and, consequently, poses technical difficulties.

Neurolytic blockade of peripheral nerves, mainly intercostal nerves, although providing a prolonged pain relief, is associated with a high incidence of neuritis. This can trigger pain that is much more difficult to control than the original one and, thus, should be reserved for patients with a very short life expectancy when other strategies have failed [127].

Clinical reports on the use of peripheral nerve blocks are limited and the lack of comparative studies compromises the establishment of recommendations for clinical practice [127].





  • Single-shot peripheral nerve blocks with local anaesthetics may be useful for acute pain control. Alternatively, catheter infusions adjacent to nerve plexuses or other peripheral nerves may provide pain relief for days or weeks.


  • Neurolytic blockade of peripheral nerves, mainly intercostal nerves, although providing a prolonged pain relief, is associated with a high incidence of neuritis.



39.17 Autonomic Nerve Blocks


Autonomic nerve blocks consist of the blockade of sympathetic nervous system fibres, which carry pain afferents from the viscera. The most commonly performed procedures are celiac plexus ablation, superior hypogastric plexus block and ganglion impar block.

Celiac plexus and splanchnic nerves block is often used to control pancreatic cancer or other upper abdominal malignancies related pain. Although there is no robust statistical evidence of a better pain control than that offered by analgesic therapy only, the fact that this technique enables lower opioid doses and, consequently, fewer side effects justifies its importance [128].

The celiac plexus lies retroperitoneally at the level of the T12 and L1 vertebrae and anterior to the aorta and carries afferent fibres from several abdominal organs including the pancreas, liver, biliary tract and bowel up to the first part of the transverse colon. The most common access route is posterior with fluoroscopy guidance, although other approaches may be useful. The ultrasound-guided anterior approach is a minimally invasive technique with increasing popularity and is believed to be a safer procedure. Nonetheless, no randomized controlled trial has shown its superiority over other methods yet [128, 129].

Contra-indications to the use of this technique include severe refractory coagulopathy or thrombocytopenia, aortic aneurysm or mural thrombosis, local or intra-abdominal infection and bowel obstruction. Large masses making anatomical structures position difficult to visualize are a relative contraindication [130].

Possible complications of these methods include diarrhoea, temporary postural hypotension, back pain and dysaesthesia. More severe side effects, including permanent motor deficit, are rare [123]. Four cases of paraplegia were reported in a review of 2,730 coeliac blocks, three of which with associated loss of anal and bladder sphincter function. These major complications were attributed to either direct spinal cord injury during the procedure or to spinal ischaemia secondary to anterior spinal artery spasm [131].

Superior hypogastric plexus block enables reduction of pain with lower abdominal or pelvic viscera origin. It carries afferents from the bladder, uterus, prostate, vagina, testes, urethra, descending colon and rectum. The hypogastric plexus lies retroperitoneally at the level of L5 and S1 vertebrae and its approach is most commonly posterior, with the patient in the prone position, under computed tomography and fluoroscopy guidance. However, an ultrasound-guided anterior approach may be useful since it can be performed with the patient lying supine and avoids radiation exposure [132]. A transdiscal approach has also been described as a safe, equally effective and easier procedure compared to the classic posterior approach [133, 134]. Potential complications of a superior hypogastric plexus block include bleeding, infection, nerve structures and visceral damage and sexual dysfunction [135].

The ganglion impar, also known as ganglion of Walther, corresponds to the distal termination of the sympathetic chains as they merge. It is generally located on the ventral aspect of the sacrococcygeal junction but may lie ventral to the coccyx. It has shown to provide pain relief for patients with pelvic and perineal cancer and effectiveness in treating radiation proctitis pain has been reported [136, 137]. The ganglion impar can be accessed via the anococcygeal ligament, in a midline or paramedian approach; via the sacrococcygeal or intercoccygeal joint spaces or via a lateral approach. A lateral approach seems to reduce the risk of perforating the rectum and avoids needle breakage when bent or inserted through ossified structures [138], but literature is contradictory regarding the best approach.

The appropriate timing for carrying out a neurolytic plexus block should be further investigated but it may be advantageous to perform it before the second step of the WHO analgesic ladder rather than the fourth step [139].





  • Celiac plexus and splanchnic nerves block is often used to control pancreatic cancer or other upper abdominal malignancies related pain.


  • Superior hypogastric plexus block enables reduction of pain with lower abdominal or pelvic viscera origin.


  • Ganglion impar block has shown to provide pain relief for patients with pelvic and perineal cancer and effectiveness in treating radiation proctitis pain has been reported.


  • These procedures present important potential complications.


39.17.1 Neuraxial Analgesia


Spinal analgesia aim is to achieve high concentrations of opioids and other drugs close to their spinal receptors, thus providing a more effective pain relief than systemic drugs with minimal side effects. It has been estimated that only around 2 % of patients receive this kind of analgesia, although 5 % or more would benefit from its use [140].

The most commonly used opioid for this purpose is morphine, although diamorphine, fentanyl, sufentanil and hydromorphone have also been used [123]. Local anesthetics, such as bupivacaine, and clonidine, when administered along with opioids, may have a synergistic effect, enabling the use lower opioid doses and, consequently, reducing adverse effects.

Neuraxial analgesia may be delivered by the epidural or by the intrathecal route. An epidural analgesia may be preferable when a focal analgesia is aimed, achieved by placing the catheter tip close to the target location. Besides, it is recommended for the heavily opioid intolerant patient who requires high drug doses delivery. The intrathecal route, on the other hand, is indicated for diffuse pain or for those patients whose epidural space is obliterated by the disease itself or by surgery [140]. Differences between intrathecal and epidural analgesia complications do not appear to be significant, but epidural catheter positioning may be easier at the cervical and thoracic levels [141].

Neuraxial infusions may utilize an external or implanted system, being performed by using one of three methods: a percutaneous catheter tunnelled subcutaneously and attached to an external pump; a subcutaneous catheter with an injection port and an external pump; and a subcutaneous catheter and implanted pump. This last option is recommended when patient life expectancy is greater than 3 months – although expensive, this approach becomes cost-effective once treatment duration becomes longer than 3 months. On the contrary, if prognosis is less than 3 months, a tunnelled catheter is usually preferred [141].

Raised intracranial pressure is an absolute contraindication to neuraxial analgesia and this technique should also be avoided in the presence of brain metastases due to the risk of herniation and haemorrhage. Local or systemic infection is also impeditive since its spread to the central nervous system may occur. Chronic use of anticoagulants does not contraindicate neuraxial analgesia and it may also be carried out in thrombocytopenic patients although, in this case, platelet transfusion may be considered before catheter insertion [142].

Despite reducing systemic analgesic-related side effects, neuraxial analgesia may also give rise to drug-related or procedure-related complications. Intrathecal opioids may produce sedation and respiratory depression since they may reach opioid receptors in the brain, by spreading rostrally in the cerebrospinal fluid. This may be avoided by administering lipophilic opioids as close to the target spinal levels as possible. Practice guidelines have been established to avoid and reverse this respiratory depression [143]. Other opioids side-effects are roughly similar to those occurring in systemic administration and have already been discussed. Intrathecal infusions of local anaesthetics or clonidine may result in hypotension. It should be stressed that cancer patients with a low intravascular volume are particularly vulnerable to this effect [142].

Nerve injury and paralysis are rare and may occur as a result from direct injury to the spinal cord, bleeding and epidural hematoma formation. Postdural puncture headaches are more frequent but, in most cases, they are self-limiting. For the remaining patients, autologous epidural blood patch or fibrin glue may be used. Local infections and meningitis, although rare, can determine catheter removal. Towards the end of life, an adequate pain control may be a priority and maintaining the catheter in place while intrathecal or systemic antibiotics are given can be an appropriate option [123]. 2011 consensus based guidelines recommend surgical site infection prophylaxis [144].





  • Spinal analgesia provides high concentrations of opioids and other drugs close to their spinal receptors, thus providing effective analgesia with minimal side effects.


  • Morphine, bupivacaine, and clonidine are the main drugs used for neuraxial analgesia and may be combined for a synergistic action.


  • An epidural analgesia may be preferable when a focal analgesia is aimed.


  • The intrathecal route is indicated for a more diffuse pain or whenever the epidural space is obliterated by the disease itself or by surgery.


  • Neuraxial infusions may utilize an external or implanted system. A fully implanted system is recommended when patient life expectancy is greater than 3 months.


  • Raised intracranial pressure is an absolute contraindication to neuraxial analgesia and this technique should also be avoided in the presence of brain metastases.


  • Intrathecal opioids may produce sedation and respiratory depression since they may reach opioid receptors in the brain, by spreading rostrally in the cerebrospinal fluid.


  • Nerve injury and paralysis are rare complications of spinal analgesia. Postdural puncture headache is more common but is usually self-limiting.


39.18 Percutaneous Kyphoplasty and Vertebroplasty


Vertebroplasty and kyphoplasty are vertebral augmentation procedures consisting of an injection of bone cement into the cancellous or spongy bone of the vertebral body to alleviate pain caused by a vertebral compression fracture. In kyphoplasty, a modification of vertebroplasty, a balloon is previously inserted and inflated in order to create a cavity and only then the bone cement is injected. There is no clear evidence indicating that one of the procedures is superior to the other [145].

Contraindications for these procedures include overt instability, cord compression with clinical myelopathy, infection at the fracture site, bleeding disorders and low platelet count. When cord compression is present without neurological symptoms, neuromonitoring or local anaesthesia with an anterior delivery of cement is advisable [145].

Serious complications are rare with polymethyl methacrylate extravasation being the most common. However, it is asymptomatic and is less frequent in kyphoplasty [145].


39.19 Conclusions


In spite of many technical and pharmacological advances, cancer pain remains a major cause of suffering resulting in poor quality of life for the patients. Cancer pain management presents many difficulties such as lack of pain assessment and education in opioids prescription including fear of side effects. New medications and invasive techniques may increase pain relief for cancer patients. However the healthcare provider should always have in mind the complexity of the total pain to find the better approach of its different dimensions contributing not only to the relief of pain, but also allowing exceedingly better quality of life to the patients consequently reducing healthcare and socio-economic burdens.


References



1.

van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J (2007) Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol 18:1437–1449PubMed


2.

Clark D (1999) ‘Total pain’, disciplinary power and the body in the work of Cicely Saunders, 1958–1967. Soc Sci Med 49:727–736PubMed


3.

Foley KM (2011) How well is cancer pain treated? Palliat Med 25:398–401PubMed


4.

Deandrea S, Montanari M, Moja L, Apolone G (2008) Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 19:1985–1991PubMedCentralPubMed


5.

Fairchild A (2010) Under-treatment of cancer pain. Curr Opin Support Palliat Care 4:11–15PubMed


6.

Twycross RG (2002) The challenge of palliative care. Int J Clin Oncol 7:271–278PubMed

Mar 25, 2016 | Posted by in INTERVENTIONAL RADIOLOGY | Comments Off on Oncological Pain and Clinical Approaches

Full access? Get Clinical Tree

Get Clinical Tree app for offline access